Role of p66shc in renal toxicity of oleic acid

American Journal of Nephrology

Volumn 38, Issue 3, 2013, Pages 226-232

  Arany, Istvan ^a   Clark, Jeb S ^a   Reed, Dustin K ^a   Juncos, Luis A ^a   Dixit, Mehul ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Depolarization; Injury; Lipotoxicity; Mitochondria; p66shc; Reactive oxygen species; Renal toxicity

Indexed keywords

CYTOCHROME C; ENZYME; LUCIFERASE; OLEIC ACID; PROTEIN P66SCH; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE; UNCLASSIFIED DRUG; CELL PROTEIN; LACTATE DEHYDROGENASE; P66SHC PROTEIN; XANTHINE OXIDASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DAMAGE; CONTROLLED STUDY; DEPOLARIZATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LIPOTOXICITY; NEPHROTOXICITY; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; ANIMAL EXPERIMENT; CELL MEMBRANE DEPOLARIZATION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; KIDNEY CELL; LUCIFERASE ASSAY; MITOCHONDRION; MOUSE; PROTEIN BINDING; PROTEIN FUNCTION; RESPIRATORY CHAIN; WESTERN BLOTTING;

ANIMALS; CELL LINE; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; KIDNEY; KIDNEY TUBULES; KIDNEY TUBULES, PROXIMAL; MICE; MITOCHONDRIA; NADPH OXIDASE; OBESITY; OLEIC ACID; PHOSPHORYLATION; PLASMIDS; PROMOTER REGIONS, GENETIC; REACTIVE OXYGEN SPECIES; RISK FACTORS; SERINE; SHC SIGNALING ADAPTOR PROTEINS;

EID: 84885081325     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000354357     Document Type: Article

References (46)

1. Lakshman R, Elks CE, Ong KK: Childhood obesity. Circulation 2012; 126: 1770-1779.
2. Fortuna JL: The obesity epidemic and food addiction: clinical similarities to drug dependence. J Psychoactive Drugs 2012; 44: 56-63.
3. Speeckaert MM, Delanghe JR, Vanholder RC: Chronic nicotine exposure and acute kidney injury: new concepts and experimental evidence. Nephrol Dial Transplant 2013; 28: 1329-1331.
4. Gunta SS, Mak RH: Is obesity a risk factor for chronic kidney disease in children? Pediatr Nephrol 2012, E-pub ahead of print.
5. Szromba C: Understanding obesity and chronic kidney disease. Nephrol Nurs J 2012; 39: 131-135; quiz 136.
6. Bayliss G, Weinrauch LA, D'Elia JA: Pathophysiology of obesity-related renal dysfunction contributes to diabetic nephropathy. Curr Diab Rep 2012; 12: 440-446.
7. Schaffer JE: Lipotoxicity: When tissues overeat. Curr Opin Lipidol 2003; 14: 281-287.
8. Weinberg JM: Lipotoxicity. Kidney Int 2006; 70: 1560-1566.
9. Ishola DA Jr, Post JA, van Timmeren MM, Bakker SJ, Goldschmeding R, Koomans HA, Braam B, Joles JA: Albumin-bound fatty acids induce mitochondrial oxidant stress and impair antioxidant responses in proximal tubular cells. Kidney Int 2006; 70: 724-731.
10. Feldkamp T, Kribben A, Roeser NF, Senter RA, Weinberg JM: Accumulation of nonesterified fatty acids causes the sustained energetic deficit in kidney proximal tubules after hypoxia-reoxygenation. Am J Physiol Renal Physiol 2006; 290:F465-F477.
11. Rosca MG, Vazquez EJ, Chen Q, Kerner J, Kern TS, Hoppel CL: Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes 2012; 61: 2074-2083.
12. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, Pelicci PG: Electron transfer between cytochrome c and p66shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005; 122: 221-233.
13. Arany I, Clark JS, Ember I, Juncos LA: Epigenetic modifiers exert renal toxicity through induction of p66shc. Anticancer Res 2011; 31: 3267-3271.
14. Arany I, Clark JS, Reed DK, Ember I, Juncos LA: Cisplatin enhances interaction between p66shc and hsp27: its role in reorganization of the actin cytoskeleton in renal proximal tubule cells. Anticancer Res 2012; 32: 4759-4763.
15. Arany I, Faisal A, Clark JS, Vera T, Baliga R, Nagamine Y: p66shc-mediated mitochondrial dysfunction in renal proximal tubule cells during oxidative injury. Am J Physiol Renal Physiol 2010; 298:F1214-F1221.
16. Arany I, Faisal A, Nagamine Y, Safirstein RL: p66shc inhibits pro-survival epidermal growth factor receptor/erk signaling during severe oxidative stress in mouse renal proximal tubule cells. J Biol Chem 2008; 283: 6110-6117.
17. Clark JS, Faisal A, Baliga R, Nagamine Y, Arany I: Cisplatin induces apoptosis through the erk-p66shc pathway in renal proximal tubule cells. Cancer Lett 2010; 297: 165-170.
18. Ernest S, Bello-Reuss E: Expression and function of P-glycoprotein in a mouse kidney cell line. Am J Physiol 1995; 269:C323-C333.
19. Kim CS, Jung SB, Naqvi A, Hoffman TA, De-Ricco J, Yamamori T, Cole MP, Jeon BH, Irani K: p53 impairs endothelium-dependent vasomotor function through transcriptional upregulation of p66shc. Circ Res 2008; 103: 1441-1450.
20. Katsoulieris E, Mabley JG, Samai M, Sharpe MA, Green IC, Chatterjee PK: Lipotoxicity in renal proximal tubular cells: relationship between endoplasmic reticulum stress and oxidative stress pathways. Free Radic Biol Med 2010; 48: 1654-1662.
21. Portilla D: Energy metabolism and cytotoxicity. Semin Nephrol 2003; 23: 432-438.
22. Bobulescu IA: Renal lipid metabolism and lipotoxicity. Curr Opin Nephrol Hypertens 2010; 19: 393-402.
23. Abid MR, Razzaque MS, Taguchi T: Oxidant stress in renal pathophysiology. Contrib Nephrol. Basel, Karger, 2005, vol 148, pp 135-153.
24. Wardle EN: Cellular oxidative processes in relation to renal disease. Am J Nephrol 2005; 25: 13-22.
25. Safirstein RL: Acute renal failure: from renal physiology to the renal transcriptome. Kidney Int 2004; 66:S62-S66.
26. Devarajan P: Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 2006; 17: 1503-1520.
27. Chatterjee PK: Novel pharmacological approaches to the treatment of renal ischemiareperfusion injury: a comprehensive review. Naunyn Schmiedebergs Arch Pharmacol 2007; 376: 1-43.
28. Genestra M: Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Cell Signal 2007; 19: 1807-1819.
29. Droge W: Free radicals in the physiological control of cell function. Physiol Rev 2002; 82: 47-95.
30. Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM: Mechanisms of cell death in oxidative stress. Antioxid Redox Signal 2007; 9: 49-89.
31. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ: Production of reactive oxygen species by mitochondria: central role of complex III. J Biol Chem 2003; 278: 36027-36031.
32. Kushnareva Y, Murphy AN, Andreyev A: Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state. Biochem J 2002; 368: 545-553.
33. Becker LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004; 61: 461-470.
34. Pellegrini M, Pacini S, Baldari CT: p66shc: the apoptotic side of shc proteins. Apoptosis 2005; 10: 13-18.
35. Orsini F, Migliaccio E, Moroni M, Contursi C, Raker VA, Piccini D, Martin-Padura I, Pelliccia G, Trinei M, Bono M, Puri C, Tacchetti C, Ferrini M, Mannucci R, Nicoletti I, Lanfrancone L, Giorgio M, Pelicci PG: The life span determinant p66shc localizes to mitochondria where it associates with mitochondrial heat shock protein 70 and regulates transmembrane potential. J Biol Chem 2004; 279: 25689-25695.
36. Stremmel W, Pohl L, Ring A, Herrmann T: A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids. Lipids 2001; 36: 981-989.
37. Srivastava S, Chan C: Hydrogen peroxide and hydroxyl radicals mediate palmitate-induced cytotoxicity to hepatoma cells: relation to mitochondrial permeability transition. Free Radic Res 2007; 41: 38-49.
38. Honda HM, Korge P, Weiss JN: Mitochondria and ischemia/reperfusion injury. Ann NY Acad Sci 2005; 1047: 248-258.
39. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, Herman B: The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998; 1366: 177-196.
40. Napoli C, Martin-Padura I, de Nigris F, Giorgio M, Mansueto G, Somma P, Condorelli M, Sica G, De Rosa G, Pelicci P: Deletion of the p66shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet. Proc Natl Acad Sci USA 2003; 100: 2112-2116.
41. Berniakovich I, Trinei M, Stendardo M, Migliaccio E, Minucci S, Bernardi P, Pelicci PG, Giorgio M: p66shc-generated oxidative signal promotes fat accumulation. J Biol Chem 2008; 283: 34283-34293.
42. Trinei M, Giorgio M, Cicalese A, Barozzi S, Ventura A, Migliaccio E, Milia E, Padura IM, Raker VA, Maccarana M, Petronilli V, Minucci S, Bernardi P, Lanfrancone L, Pelicci PG: A p53-p66shc signalling pathway controls intracellular redox status, levels of oxidation-damaged DNA and oxidative stress-induced apoptosis. Oncogene 2002; 21: 3872-3878.
43. Arany I, Clark J, Reed DK, Juncos LA: Chronic nicotine exposure augments renal oxidative stress and injury through transcriptional activation of p66shc. Nephrol Dial Transplant 2013;28:1417-1425.
44. Ventura A, Luzi L, Pacini S, Baldari CT, Pelicci PG: The p66shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J Biol Chem 2002; 277: 22370-22376.
45. Cury-Boaventura MF, Pompeia C, Curi R: Comparative toxicity of oleic acid and linoleic acid on jurkat cells. Clin Nutr 2004; 23: 721-732.
46. Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS: Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008; 57: 451-459.